Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BESPONSA INJECTION 1MG SPECIAL INVESTIGATION (PEDIATRIC INVESTIGATION)

NCT06476665 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT06476665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06476665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BESPONSA INJECTION 1MG SPECIAL INVESTIGATION (PEDIATRIC INVESTIGATION)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Active, not recruiting
Start date
November 7, 2024
Completion date
June 22, 2029
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphocytic leukemia